Johan Neyts

Papers

Total Citations

H-Index

About

Johan Neyts is a prominent virologist whose research sits at the critical intersection of antiviral drug discovery and infectious disease preparedness. His work has made substantial contributions to combating some of the world's most pressing viral threats, including dengue virus and SARS-CoV-2. Neyts has been instrumental in developing innovative high-throughput screening (HTS) assays that accelerate the identification of antiviral compounds, significantly streamlining the early stages of drug discovery pipelines. Among his notable contributions is the development of a dengue type 2 reporter virus assay utilizing mCherry fluorescent protein, enabling rapid, scalable screening of potential antidrug candidates against a pathogen endangering nearly half the global population. His team similarly responded to the COVID-19 pandemic with urgency, constructing a robust dual-reporter HTS platform for SARS-CoV-2 antiviral research, garnering 14 citations and reflecting his adaptability to emerging infectious disease crises. Collectively, his cited works demonstrate a research philosophy centered on translational impact — bridging laboratory innovation with real-world therapeutic needs. With a growing citation record across multiple viral disease contexts, Neyts stands as an influential figure in antiviral science, inspiring the next generation of researchers tackling global health challenges.